Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Nautilus Biotechnology, Inc. (NAUT)

Abeona Therapeutics Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Nautilus Biotechnology, Inc. are of similar size ($274.9M and $265.9M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −242.6%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 14 metrics below, Nautilus Biotechnology, Inc. leads on 9 and Abeona Therapeutics Inc. on 5.

Valuation

Metric ABEO NAUT Biotechnology median
P/E n/m n/m 8.50
P/S 9.68 n/m 9.71
P/B 1.96 2.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.60 n/m 9.21
Earnings yield (26.59%) (21.84%) (33.15%)
Free cash flow yield (32.48%) (19.80%) (25.50%)

Profitability

Metric ABEO NAUT Biotechnology median
Gross margin 66.03% 0.00% 65.16%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (36.21%) (56.36%)
Return on assets (29.54%) (30.00%) (48.04%)
Return on invested capital 0.00% (83.32%) 0.00%

Growth

Metric ABEO NAUT Biotechnology median
Revenue growth (TTM) 427.47% — 6.02%
EPS growth (last fiscal year) 165.16% 16.07% 30.26%
Revenue growth, 5-year CAGR 14.19% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO NAUT Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 10.14 4.72
Net debt to EBITDA 2.00 1.67 0.96

Dividend

Metric ABEO NAUT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO NAUT Biotechnology median
Market cap 265.90m 274.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack